SCOPIA CAPITAL MANAGEMENT LP
CIK 1279150 · last filed 2019-05-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$597.43M
Companies
4
Total Filings
27
Lifetime Open-Market Net
$119.04M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ITRI | 10%+ Owner | 3,926,804 | $83.93 | $329.58M | $164.32M | 11 | 2019-05-30 |
| Acorda Therapeutics, Inc. (ACOR) Delisted | 10%+ Owner | 39,643 | $0.66 | $26.2K | -$49.11M | 9 | 2019-01-28 |
| Barzel Industries Inc. (TONSW) Delisted | 10%+ Owner | 2,634,673 | — | — | $0 | 1 | 2008-08-13 |
| CENT | 10%+ Owner | 6,232,134 | $42.98 | $267.86M | $3.83M | 6 | 2008-05-23 |
Recent Filings · Page 2 of 3
27 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-10-12 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −574,304 | -$9.75M | EDGAR |
| 2018-10-04 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −505,856 | -$9.69M | EDGAR |
| 2018-09-06 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −137,140 | -$3.94M | EDGAR |
| 2018-07-17 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −133,196 | -$4.00M | EDGAR |
| 2017-12-29 | ITRI | Buy (P) | +94,944 | $6.46M | EDGAR |
| 2017-12-27 | ITRI | Buy (P) | +87,316 | $5.93M | EDGAR |
| 2017-12-08 | ITRI | Buy (P) | +2,167,012 | $150.47M | EDGAR |
| 2016-09-14 | ITRI | Buy (P) | +333,212 | $17.94M | EDGAR |
| 2016-03-08 | ITRI | Buy (P) | +209,312 | $8.68M | EDGAR |
| 2016-02-12 | ITRI | Mixed | +160,164 | $5.50M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.